AMAG Issues Drug Recall Anemia Drug after Patient Death

Pharmaceutical Company Receives Report of Patient Death, Issues Drug Recall

Amag Pharmaceuticals, partnered with Takeda Pharmaceuticals, which has recently come under fire for their potentially dangerous Type 2 diabetes drug Actos, issued a drug recall for their anemia drug after reports of patient illness, and one death.

Amag has issued a drug recall for all batches of Feraheme, sold as Riesno in Switzerland, where the patient died. The company says it will investigate the problem, and gather data on safety reports, in their securities filing.

“This decision is based on a cluster of four post-marketing adverse event reports in Switzerland concerning hypersensitivity reactions of varying severity following the administration of Rienso from this batch,” Amag said in the filing, adding that new batches won’t be introduced in Switzerland until regulators approve.

Takeda called the drug recall a “precautionary measure,” saying that hypersensitivity reactions are one of the potential side effects listed on the bottle.

Riesno was approved last August to treat anemia in patients with chronic kidney disease.

According to Swissmedic, there have been four reports of acute hypersensitivity reactions through the Vigilance surveillance system. As only 1,000 ampules of the drug have been supplied to Switzerland this year, that means the number of reports is “several times higher” than expected, based on previous experience internationally.

Shares of Amag Pharmaceuticals dropped about 4.2% after the news regarding the voluntary drug recall broke.

Drug Recalls and Personal Injury

Did you know that every year approximately 200,000 Americans die from prescription drug reactions? While the U.S. government pours billions of dollars into illegal drug interdiction every year, more Americans die from legal, prescription drugs than illegal ones.

Every year, thousands of consumers sustain serious injuries from defective products. A defective product lawyer can help you with an injury you may receive. Many of these injuries could be avoided if the manufacturers or distributors of these products took additional steps to ensure consumer safety. Defective products that commonly cause injuries include medical devices, pharmaceutical products, and other defective products such as toys, cars and automotive parts.

There are a number of reasons that defective products make it to our shelves:

  • Defective manufacturing

  • Inadequate testing

  • Design defects

  • Marketing Misrepresentation

Consumers that have been harmed by defective products such as drugs, medical devices, or other products, may be eligible to receive legal remedies. Such legal remedies, or damages, may include compensation for medical expenses, lost wages, loss of physical capacity, pain, suffering, and mental anguish. Punitive damages are also available in many jurisdictions to punish defendants in those cases involving particularly egregious conduct which demonstrates a reckless or wanton disregard for the safety of the public.

The Strom Law Firm Can Help with Defective Drug Recall Cases

Strom Law Firm, L.L.C. is a leader in the consumer protection battle against dangerous prescription drugs and medical devices. We represent individuals who have been killed or injured by defective pharmaceuticals, or drug recalls that came too late. If you or a family member have been injured or killed after using a dangerous drugs or medical products such as Omontys, contact our defective drug lawyers as soon as possible so that we can begin taking steps to preserve evidence and your claim immediately. We offer free consultations to discuss the facts of your case. 803.252.4800



Follow us

Sign Up For Our Newsletter!